glp-1 substance use disorder medications get at the heart of addiction, study finds GLP‑1 drugs may fight addiction
Description
Maria Gonzalez-Rellan, sought to understand why semaglutide appeared to improve markers of MASH regardless of whether participants lost weight in clinical trials

W obecnoci sygnau GLP-1 wraliwo na GIP zostaje przywrcona, a oba sygnay sumuj si: silniejszy insulinotropizm plus wkad GIP w metabolizm lipidw adipocytw

Spatial transcriptomics in health and disease

Joint Bone Spine
They bundle it all into tiered programmes with catchy names

doi: 10.1007/s13300-021-01139-2
